Tus kws kho mob
2020 June Bulletins
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 01, 2020
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 1411 - 1420 ntawm 4179
Tus kws kho mob
P44-20 Radiation Oncology Clinical Guideline Updates for Fully Insured Commercial and Medicare Advantage Subscribers – eviCore Healthcare Specialty Utilization Management (UM) Program
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 01, 2020
Tus kws kho mob
QP47-20 Provider Cost Data Update
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 27, 2020
Tus kws kho mob
QP20-20 Medical Drug Update for New to Market Teprotumumab-trbw (Tepezza)
Hnub Tim pib siv tau lub khoos kas: Lub Ob Hlis Ntuj Tim 12, 2020
Tus kws kho mob
QP20R1-20 Update: Medical Drug Update for Teprotumumab (Tepezza)
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 13, 2020
Tus kws kho mob
QP46-20 Validation of National Drug Codes Submitted with Medical Drug Claims
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 13, 2020
Tus kws kho mob
QP45-20 Preventive Care Provided Via Telehealth
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 13, 2020
Tus kws kho mob
QP43-20 Medical Drug Update for New to Market Valoctocogene Roxaparvovec (Valrox)
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 13, 2020
Tus kws kho mob
QP44-20 Non-Covered Medicare Services and Organization Determination Reminder for Platinum Blue and Medicare Advantage Subscribers
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 13, 2020
Tus kws kho mob
P29-20 Sequestration Suspension for Medicare Lines of Business
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 01, 2020